NEW YORK (Reuters Health) – As a mass screening tool for diabetes and pre-diabetes in China, the fasting capillary blood glucose (FCG) test performs better than the hemoglobin…
NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
NEW YORK (Reuters Health) – The benefits of statins are variable and depend on the agent being taken, a meta-analysis has shown. Pooled data from 10 randomized trials…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
NEW YORK (Reuters Health) – While the risk of stroke after a transient ischemic attack (TIA) is highest in the first few days, stroke risk remains elevated even…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – Endoscopic resection of large colonic polyps is a safe and cost-effective alternative to surgery, according to a paper in the December issue of…
NEW YORK (Reuters Health) – Outpatient infusions of ketamine can significantly improve the severe pain of complex regional pain syndrome, a chronic problem after trauma, a small study…
NEW YORK (Reuters Health) – Nearly all patients have complications from chemoradiation for head and neck cancer, a study in the Archives of Otolaryngology: Head and Neck Surgery…
NEW YORK (Reuters Health) – Many common medications – including some antidepressants and antihypertensives – can interfere with a test that distinguishes Cushing’s syndrome from pseudo-Cushing’s syndrome, investigators…
